International Bladder Cancer Group Intermediate-risk Nonmuscle-invasive Bladder Cancer Scoring System Predicts Outcomes of Patients on Active Surveillance-Reference-Cited by-同舟云学术

International Bladder Cancer Group Intermediate-risk Nonmuscle-invasive Bladder Cancer Scoring System Predicts Outcomes of Patients on Active Surveillance

Published:2023-11 Issue:5 Volume:210 Page:763-770
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Tan Wei Shen¹^ORCID,Contieri Roberto¹²³,Buffi Nicolò Maria²³,Lughezzani Giovanni²³,Grajales Valentina¹,Soloway Mark⁴,Casale Paolo³,Hurle Rodolfo³,Kamat Ashish M.¹

Affiliation:

1. Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas

2. Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy

3. Department of Urology, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy

4. Division of Urology, Memorial Cancer Institute, Memorial Hospital, Hollywood, Florida

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Link

http://www.auajournals.org/doi/pdf/10.1097/JU.0000000000003639

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)—A Summary of the 2024 Guidelines Update;European Urology;2024-08

2. Deintensification of Treatment for Low-grade Bladder Tumors: A Collaborative Review by the International Bladder Cancer Group (IBCG);European Urology Oncology;2024-08

3. Aktive Überwachung beim nicht muskelinvasiven Blasenkarzinom;Aktuelle Urologie;2024-07-24

4. Clinical Validation of the Intermediate-risk Non–muscle-invasive Bladder Cancer Scoring System and Substratification Model Proposed by the International Bladder Cancer Group: A Multicenter Young Academic Urologists Urothelial Working Group Collaboration;European Urology Oncology;2024-06

5. Hematuria Cancer Risk Score with Ultrasound Informs Cystoscopy Use in Patients with Hematuria;European Urology Oncology;2024-05